Kai Wille

13PUBLICATIONS
73CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursPredictive and prognostic markersAfrican languagesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 10, 2026
Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study.

|Sep 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Katja Krüger, Razif Gabdoulline, Martin Wichmann

|Dec 11, 2024
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff

|Sep 10, 2024
Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid Leukemia.

Kai Wille, Marvin Dumke, Nadine Wilsdorf

|Oct 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity.

Beate Heissig, Yousef Salama, Roman Iakoubov

|Apr 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.

Jonathan F Brozat, Frank Hanses, Martina Haelberger

Pageof 3

Frequent Collaborators

1 joint publications

Tiziano Barbui

1 joint publications

Valerio De Stefano

1 joint publications

Alessandra Carobbio

1 joint publications

Alessandra Iurlo